Barclays Lowers Sotera Health (NASDAQ:SHC) Price Target to $12.00

Sotera Health (NASDAQ:SHC) had its price objective decreased by analysts at Barclays from $16.00 to $12.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s target price points to a potential upside of 14.18% from the company’s previous close.

Sotera Health Trading Down 0.8 %

Shares of SHC opened at $10.51 on Thursday. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The stock has a market cap of $2.98 billion, a PE ratio of 42.04 and a beta of 1.88. Sotera Health has a 1 year low of $9.53 and a 1 year high of $17.08. The stock has a 50 day simple moving average of $12.15 and a 200-day simple moving average of $13.52.

Institutional Investors Weigh In On Sotera Health

Several institutional investors and hedge funds have recently made changes to their positions in SHC. Blue Trust Inc. lifted its holdings in Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after purchasing an additional 1,140 shares during the last quarter. Quarry LP acquired a new stake in shares of Sotera Health during the fourth quarter worth approximately $28,000. GAMMA Investing LLC increased its holdings in shares of Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after buying an additional 1,121 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock valued at $82,000 after acquiring an additional 1,640 shares during the last quarter. Finally, Sterling Capital Management LLC boosted its holdings in shares of Sotera Health by 58.5% in the 4th quarter. Sterling Capital Management LLC now owns 9,029 shares of the company’s stock worth $124,000 after acquiring an additional 3,331 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.